Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00876694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Indacaterol 300 µg
DRUG: Salmeterol 50 µg

Sponsor

Novartis Pharmaceuticals